Potassium plays a key role in maintaining cell function. Almost all cells possess an Na+-K+-ATPase, which pumps Na+ out of the cell and K+ into the cell and leads to a K+ gradient across the cell membrane (K+in>K+out) that is partially responsible for maintaining the potential difference across the membrane. This potential difference is critical to the function of cells, particularly in excitable tissues, such as nerve and muscle. The body has developed numerous mechanisms for defense of serum K+. These mechanisms serve to maintain a proper distribution of K+ within the body as well as regulate the total body K+ content.
Internal Balance of K+
The kidney is primarily responsible for maintaining total body K+ content by matching K+ intake with K+ excretion. Adjustments in renal K+ excretion occur over several hours; therefore, changes in extracellular K+ concentration are initially buffered by movement of K+ into or out of skeletal muscle. The regulation of K+ distribution between the intracellular and extracellular space is referred to as internal K+ balance. The most important factors regulating this movement under normal conditions are insulin and catecholamines (1).
After a meal, the postprandial release of insulin functions to not only regulate the serum glucose concentration but also shift dietary K+ into cells until the kidney excretes the K+ load re-establishing K+ homeostasis. These effects are mediated through insulin binding to cell surface receptors, which stimulates glucose uptake in insulin-responsive tissues through the insertion of the glucose transporter protein GLUT4 (2,3). An increase in the activity of the Na+-K+-ATPase mediates K+ uptake (Figure 1). In patients with the metabolic syndrome or CKD, insulin-mediated glucose uptake is impaired, but cellular K+ uptake remains normal (4,5), demonstrating differential regulation of insulin-mediated glucose and K+ uptake.
Catecholamines regulate internal K+ distribution, with α-adrenergic receptors impairing and β-adrenergic receptors promoting cellular entry of K+. β2-Receptor–induced stimulation of K+ uptake is mediated by activation of the Na+-K+-ATPase pump. These effects play a role in regulating the cellular release of K+ during exercise (6).
Under normal circumstances, exercise is associated with movement of intracellular K+ into the interstitial space in skeletal muscle. Increases in interstitial K+ can be as high as 10–12 mM with severe exercise. Accumulation of K+ is a factor limiting the excitability and contractile force of muscle accounting for the development of fatigue (7,8). Additionally, increases in interstitial K+ play a role in eliciting rapid vasodilation, allowing for blood flow to increase in exercising muscle (9). During exercise, release of catecholamines through β2 stimulation limits the rise in extracellular K+ concentration that otherwise occurs as a result of normal K+ release by contracting muscle. Although the mechanism is likely to be multifactorial, total body K+ depletion may blunt the accumulation of K+ into the interstitial space, limiting blood flow to skeletal muscle and accounting for the association of hypokalemia with rhabdomyolysis.
Changes in plasma tonicity and acid–base disorders also influence internal K+ balance. Hyperglycemia leads to water movement from the intracellular to extracellular compartment. This water movement favors K+ efflux from the cell through the process of solvent drag. In addition, cell shrinkage causes intracellular K+ concentration to increase, creating a more favorable concentration gradient for K+ efflux. Mineral acidosis, but not organic acidosis, can be a cause of cell shift in K+. As recently reviewed, the general effect of acidemia to cause K+ loss from cells is not because of a direct K+-H+ exchange, but, rather, is because of an apparent coupling resulting from effects of acidosis on transporters that normally regulate cell pH in skeletal muscle (10) (Figure 2).
Intracellular K+ serves as a reservoir to limit the fall in extracellular K+ concentrations occurring under pathologic conditions where there is loss of K+ from the body. The efficiency of this effect was shown by military recruits undergoing training in the summer (11). These subjects were able to maintain a near-normal serum K+ concentration despite daily sweat K+ loses of >40 mmol and an 11-day cumulative total body K+ deficit of approximately 400 mmol.
Studies in rats using a K+ clamp technique afforded insight into the role of skeletal muscle in regulating extracellular K+ concentration (12). With this technique, insulin is administered at a constant rate, and K+ is simultaneously infused at a rate designed to prevent any drop in plasma K+ concentration. The amount of K+ administered is presumed to be equal to the amount of K+ entering the intracellular space of skeletal muscle.
In rats deprived of K+ for 10 days, the plasma K+ concentration decreased from 4.2 to 2.9 mmol/L. Insulin-mediated K+ disappearance declined by more than 90% compared with control values. This decrease in K+ uptake was accompanied by a >50% reduction in both the activity and expression of muscle Na+-K+-ATPase, suggesting that decreased pump activity might account for the decrease in insulin effect. This decrease in muscle K+ uptake, under conditions of K+ depletion, may limit excessive falls in extracellular K+ concentration that occur under conditions of insulin stimulation. Concurrently, reductions in pump expression and activity facilitate the ability of skeletal muscle to buffer declines in extracellular K+ concentrations by donating some component of its intracellular stores.
There are differences between skeletal and cardiac muscle in the response to chronic K+ depletion. Although skeletal muscle readily relinquishes K+ to minimize the drop in plasma K+ concentration, cardiac tissue K+ content remains relatively well preserved. In contrast to the decline in activity and expression of skeletal muscle Na+-K+-ATPase, cardiac Na+-K+-ATPase pool size increases in K+-deficient animals. This difference explains the greater total K+ clearance capacity after the acute administration of intravenous KCl to rats fed a K+-free diet for 2 weeks compared with K+-replete controls (13,14). Cardiac muscle accumulates a considerable amount of K+ in the setting of an acute load. When expressed on a weight basis, the cardiac capacity for K+ uptake is comparable with that of skeletal muscle under conditions of K+ depletion and may actually exceed skeletal muscle under control conditions.
Renal Potassium Handling
Potassium is freely filtered by the glomerulus. The bulk of filtered K+ is reabsorbed in the proximal tubule and loop of Henle, such that less than 10% of the filtered load reaches the distal nephron. In the proximal tubule, K+ absorption is primarily passive and proportional to Na+ and water (Figure 3). K+ reabsorption in the thick ascending limb of Henle occurs through both transcellular and paracellular pathways. The transcellular component is mediated by K+ transport on the apical membrane Na+-K+-2Cl− cotransporter (Figure 4). K+ secretion begins in the early distal convoluted tubule and progressively increases along the distal nephron into the cortical collecting duct (Figure 5). Most urinary K+ can be accounted for by electrogenic K+ secretion mediated by principal cells in the initial collecting duct and the cortical collecting duct (Figure 6). An electroneutral K+ and Cl− cotransport mechanism is also present on the apical surface of the distal nephron (15). Under conditions of K+ depletion, reabsorption of K+ occurs in the collecting duct. This process is mediated by upregulation in the apically located H+-K+-ATPase on α-intercalated cells (16) (Figure 7).
Under most homeostatic conditions, K+ delivery to the distal nephron remains small and is fairly constant. By contrast, the rate of K+ secretion by the distal nephron varies and is regulated according to physiologic needs. The cellular determinants of K+ secretion in the principal cell include the intracellular K+ concentration, the luminal K+ concentration, the potential (voltage) difference across the luminal membrane, and the permeability of the luminal membrane for K+. Conditions that increase cellular K+ concentration, decrease luminal K+ concentration, or render the lumen more electronegative will increase the rate of K+ secretion. Conditions that increase the permeability of the luminal membrane for K+ will increase the rate of K+ secretion. Two principal determinants of K+ secretion are mineralocorticoid activity and distal delivery of Na+ and water.
Aldosterone is the major mineralocorticoid in humans and affects several of the cellular determinants discussed above, leading to stimulation of K+ secretion. First, aldosterone increases intracellular K+ concentration by stimulating the activity of the Na+-K+-ATPase in the basolateral membrane. Second, aldosterone stimulates Na+ reabsorption across the luminal membrane, which increases the electronegativity of the lumen, thereby increasing the electrical gradient favoring K+ secretion. Lastly, aldosterone has a direct effect on the luminal membrane to increase K+ permeability (17).
A second principal determinant affecting K+ secretion is the rate of distal delivery of Na+ and water. Increased distal delivery of Na+ stimulates distal Na+ absorption, which will make the luminal potential more negative and, thus, increase K+ secretion. Increased flow rates also increase K+ secretion. When K+ is secreted in the collecting duct, the luminal K+ concentration rises, which decreases the diffusion gradient and slows additional K+ secretion. At higher luminal flow rates, the same amount of K+ secretion will be diluted by the larger volume such that the rise in luminal K+ concentration will be less. Thus, increases in the distal delivery of Na+ and water stimulate K+ secretion by lowering luminal K+ concentration and making the luminal potential more negative.
Two populations of K+ channels have been identified in the cells of the cortical collecting duct. The renal outer medullary K+ (ROMK) channel is considered to be the major K+-secretory pathway. This channel is characterized by having low conductance and a high probability of being open under physiologic conditions. The maxi-K+ channel (also known as the large-conductance K+ [BK] channel) is characterized by a large single channel conductance and quiescence in the basal state and activation under conditions of increased flow (18). In addition to increased delivery of Na+ and dilution of luminal K+ concentration, recruitment of maxi-K+ channels contributes to flow-dependent increased K+ secretion. Renal K+ channels are subjects of extensive reviews (19–21).
The effect of increased tubular flow to activate maxi-K+ channels may be mediated by changes in intracellular Ca2+ concentration (22). The channel is Ca2+-activated, and an acute increase in flow increases intracellular Ca2+ concentrations in the principal cell. It has been suggested that the central cilium (a structure present in principal cells) may facilitate transduction of signals of increased flow to increased intracellular Ca2+ concentration. In cultured cells, bending of primary cilia results in a transient increase in intracellular Ca2+, an effect blocked by antibodies to polycystin 2 (23). Although present in nearly all segments of the nephron, the maxi-K channel has been identified as the mediator of flow-induced K+ secretion in the distal nephron and cortical collecting duct (24).
Development of hypokalemia in type II Bartter syndrome illustrates the importance of maxi-K+ channels in renal K+ excretion (25). Patients with type II Bartter syndrome have a loss-of-function mutation in ROMK manifesting with clinical features of the disease in the perinatal period. ROMK provides the pathway for recycling of K+ across the apical membrane in the thick ascending limb of Henle. This recycling generates a lumen-positive potential that drives the paracellular reabsorption of Ca2+ and Mg2+ and provides luminal K+ to the Na+-K+-2Cl− cotransporter (Figure 4).
Mutations in ROMK decrease NaCl and fluid reabsorption in the thick limb, mimicking a loop diuretic effect, which causes volume depletion. Despite the increase in distal Na+ delivery, K+ wasting is not consistently observed, because ROMK is also the major K+-secretory pathway for regulated K+ excretion in the collecting duct. In fact, in the perinatal period, infants with this form of Bartter syndrome often exhibit a transient hyperkalemia consistent with loss of function of ROMK in the collecting duct. However, over time, these patients develop hypokalemia as a result of increased flow-mediated K+ secretion through maxi-K+ channels. Studies in an ROMK-deficient mouse model of type II Bartter syndrome are consistent with this mechanism (26). The transient hyperkalemia observed in the perinatal period is likely related to the fact that ROMK channels are functionally expressed earlier than maxi-K+ channels during the course of development.
In this regard, growing infants and children are in a state of positive K+ balance, which correlates with growth and increasing cell number. Early in development, there is a limited capacity of the distal nephron to secrete K+ because of a paucity of both apically located ROMK and maxi-K+ channels. The increase in K+-secretory capacity with maturation is initially a result of increased expression of ROMK. Several weeks later, maxi-K+ channel expression develops, allowing for flow-mediated K+ secretion to occur (reviewed in ref. 27). The limitation in distal K+ secretion is channel-specific, because the electrochemical gradient favoring K+ secretion, as determined by activity of the Na+-K+-ATPase and Na+ reabsorption, is not limiting. Additionally, increased flow rates are accompanied by appropriate increases in Na+ reabsorption and intracellular Ca2+ concentrations in the distal nephron, despite the absence of stimulatory effect on K+ secretion (28). Activity of the H+- K+-ATPase, which couples K+ reabsorption to H+ secretion in intercalated cells, is similar in newborns and adults. K+ reabsorption through this pump, combined with decreased expression of K+-secretory channels, helps maintain a state of positive K+ balance during somatic growth after birth. These features of distal K+ handling by the developing kidney are a likely explanation for the high incidence of nonoliguric hyperkalemia in preterm infants (29).
Another physiologic state characterized by a period of positive K+ balance is pregnancy, where approximately 300 mEq K+ is retained (30). High circulating levels of progesterone may play a role in this adaptation through stimulatory effects on K+ and H+ transport by the H+-K+α2-ATPase isoform in the distal nephron (31).
In addition to stimulating maxi-K+ channels, increased tubular flow has been shown to stimulate Na+ absorption through the epithelial Na+ channel (ENaC) in the collecting duct. This increase in absorption not only is because of increased delivery of Na+, but also seems to be the result of mechanosensitive properties intrinsic to the channel. Increased flow creates a shear stress that activates ENaCs by increasing channel open probability (32,33).
It has been hypothesized that biomechanical regulation of renal tubular Na+ and K+ transport in the distal nephron may have evolved as a response to defend against sudden increases in extracellular K+ concentration that occur in response to ingestion of K+-rich diets typical of early vertebrates (22). According to this hypothesis, an increase in GFR after a protein-rich meal would lead to an increase in distal flow activating the ENaC, increasing intracellular Ca2+ concentration, and activating maxi-K+ channels. These events would enhance K+ secretion, thus providing a buffer to guard against development of hyperkalemia.
In patients with CKD, loss of nephron mass is counterbalanced by an adaptive increase in the secretory rate of K+ in remaining nephrons such that K+ homeostasis is generally well maintained until the GFR falls below 15–20 ml/min (34). The nature of the adaptive process is thought to be similar to the adaptive process that occurs in response to high dietary K+ intake in normal subjects (35). Chronic K+ loading in animals augments the secretory capacity of the distal nephron, and, therefore, renal K+ excretion is significantly increased for any given plasma K+ level. Increased K+ secretion under these conditions occurs in association with structural changes characterized by cellular hypertrophy, increased mitochondrial density, and proliferation of the basolateral membrane in cells in the distal nephron and principal cells of the collecting duct. Increased serum K+ and mineralocorticoids independently initiate the amplification process, which is accompanied by an increase in Na+-K+-ATPase activity.
Under conditions of volume depletion, activation of the renin-angiotensin system leads to increased aldosterone release. The increase in circulating aldosterone stimulates renal Na+ retention, contributing to the restoration of extracellular fluid volume, but occurs without a demonstrable effect on renal K+ secretion. Under condition of hyperkalemia, aldosterone release is mediated by a direct effect of K+ on cells in the zona glomerulosa. The subsequent increase in circulating aldosterone stimulates renal K+ secretion, restoring the serum K+ concentration to normal, but does so without concomitant renal Na+ retention.
The ability of aldosterone to signal the kidney to stimulate salt retention without K+ secretion in volume depletion and stimulate K+ secretion without salt retention in hyperkalemia has been referred to as the aldosterone paradox (36). In part, this ability can be explained by the reciprocal relationship between urinary flow rates and distal Na+ delivery with circulating aldosterone levels. Under conditions of volume depletion, proximal salt and water absorption increase, resulting in decreased distal delivery of Na+ and water. Although aldosterone levels are increased, renal K+ excretion remains fairly constant, because the stimulatory effect of increased aldosterone is counterbalanced by the decreased delivery of filtrate to the distal nephron. Under condition of an expanded extracellular fluid volume, distal delivery of filtrate is increased as a result of decreased proximal tubular fluid reabsorption. Once again, renal K+ excretion remains relatively constant in this setting, because circulating aldosterone levels are suppressed. It is only under pathophysiologic conditions that increased distal Na+ and water delivery are coupled to increased aldosterone levels. Renal K+ wasting will occur in this setting (37) (Figure 8).
Renal K+ secretion also remains stable during changes in flow rate resulting from variations in circulating vasopressin. In this regard, vasopressin has a stimulatory effect on renal K+ secretion (38,39). This kaliuretic property may serve to oppose a tendency to K+ retention under conditions of antidiuresis when a low-flow rate-dependent fall in distal tubular K+ secretion might otherwise occur. In contrast, suppressed endogenous vasopressin leads to decreased activity of the distal K+-secretory mechanism, thus limiting excessive K losses under conditions of full hydration and water diuresis.
Although the inverse relationship between aldosterone levels and distal delivery of salt and water serves to keep renal K+ excretion independent of volume status, recent reviews have suggested a more complex mechanism centered on the with no lysine [K] 4 (WNK4) protein kinase in the distal nephron (40,41). WNK4 is one of four members of a family of serine-threonine kinases each encoded by a different gene and characterized by the atypical placement of the catalytic lysine residue that is present in most other protein kinases. Inactivating mutations in WNK4 lead to development of pseudohypoaldosteronism type II (PHAII; Gordon syndrome). This disorder is inherited in an autosomal dominant fashion and is characterized by hypertension and hyperkalemia (42). Circulating aldosterone levels are low, despite the presence of hyperkalemia. Thiazide diuretics are particularly effective in treating both the hypertension and hyperkalemia (43).
Wild-type WNK4 acts to reduce surface expression of the thiazide-sensitive Na+-Cl− cotransporter and also stimulates clathrin-dependent endocytosis of ROMK in the collecting duct (44,45). The inactivating mutation of WNK4 responsible for PHAII leads to increased cotransporter activity and further stimulates endocytosis of ROMK. The net effect is increased NaCl reabsorption combined with decreased K+ secretion. Mutated WNK4 also enhances paracellular Cl− permeability caused by increased phosphorylation of claudins, which are tight junction proteins involved in regulating paracellular ion transport (46). In addition to increasing Na+ retention, this change in permeability further impairs K+ secretion, because the lumen-negative voltage, which normally serves as a driving force for K+ secretion, is dissipated.
Because development of hypertension and hyperkalemia resulting from the PHAII-mutated WNK4 protein can be viewed as an exaggerated response to a reduction in extracellular fluid volume (salt retention without increased K+ secretion), it has been proposed that wild-type WNK4 may act as a molecular switch determining balance between renal NaCl reabsorption and K+ secretion (45,47). Under conditions of volume depletion, the switch would be altered in a manner reminiscent of the PHAII mutant such that NaCl reabsorption is increased, but K+ secretion is further inhibited. However, when increased serum K+ concentration occurs in the absence of volume depletion, WNK4 alterations result in maximal renal K+ secretion without Na+ retention.
Angiotensin II (AII) has emerged as an important modulator of this switch. Under conditions of volume depletion, AII and aldosterone levels are increased (Figure 9). In addition to effects leading to enhanced NaCl reabsorption in the proximal tubule, AII activates the Na+-Cl− cotransporter in a WNK4-dependent manner, and it is primarily located in the initial part of the distal convoluted tubule (DCT; DCT1) (48,49). AII also activates ENaC, which is found in the aldosterone-sensitive distal nephron (ASDN) comprised of the second segment of the DCT (DCT2), the connecting tubule, and the collecting duct (50). The activation of ENaC by AII is additive to that of aldosterone (51). In this manner, AII and aldosterone act in concert to stimulate Na+ retention. At the same time, AII inhibits ROMK by both WNK4-dependent and -independent mechanisms (52,53). This inhibitory effect on ROMK along with decreased Na+ delivery to the collecting duct brought about by AII stimulation of Na+ reabsorption in the proximal nephron, and DCT1 allows for simultaneous Na+ conservation without K+ wasting.
Hyperkalemia, or an increase in dietary K+ intake, can increase renal K+ secretion independent of change in mineralocorticoid activity and without causing volume retention. This effect was shown in Wistar rats fed a diet very low in NaCl and K+ for several days and given a pharmacologic dose of deoxycorticosterone to ensure a constant and nonvariable effect of mineralocorticoids (54,55). After a KCl load administered into the peritoneal cavity, two distinct phases were noted. In the first 2 hours, there was a large increase in the rate of renal K+ excretion that was largely caused by an increase in the K+ concentration in the cortical collecting duct. During this early phase, flow through the collecting duct increased only slightly, suggesting that changes in K+ concentration were largely caused by an increase in K+-secretory capacity of the collecting duct. This effect would be consistent with known effects of dietary supplementation of K+ to increase channel density of both ROMK and maxi-K+ channels (56).
In the subsequent 4 hours, renal K+ excretion continued to be high, but during this second phase, the kaliuresis was mostly accounted for by increased flow through the collecting duct. The increased flow was attributed to an inhibitory effect of increased interstitial K+ concentration on reabsorption of NaCl in the upstream ascending limb of Henle, an effect supported by microperfusion studies in the past (57,58). The timing of the two phases is presumably important, because higher flows would be most effective in promoting kaliuresis only after establishment of increased channel density. Although older studies are consistent with decreased Na+ absorption in the thick limb and proximal nephron after increased K+ intake, inhibitory effects in these high-capacity segments lack the precision and timing necessary to ensure that downstream delivery of Na+ is appropriate to maximally stimulate K+ secretion and at the same time, not be excessive, predisposing to volume depletion, particularly in the setting of a low Na+ diet (57–59).
The low-capacity nature of the DCT and its location immediately upstream from the ASDN make this segment a more likely site for changes in dietary K+ intake to modulate Na+ transport and ensure that downstream delivery of Na+ is precisely the amount needed to ensure maintenance of K+ homeostasis without causing unwanted effects on volume. In this regard, increased dietary K+ intake leads to an inhibitory effect on Na+ transport in this segment and does so through effects on WNK1, another member of the WNK family of kinases (60,61). WNK1 is ubiquitously expressed throughout the body in multiple spliced forms. By contrast, a shorter WNK1 transcript lacking the amino terminal 1–437 amino acids of the long transcript is highly expressed in the kidney but not other tissues, and it is referred to as kidney-specific WNK1 (KS-WNK1). KS-WNK1 is restricted to the DCT and part of the connecting duct and functions as a physiologic antagonist to the actions of long WNK1. Changes in the ratio of KS-WNK1 and long WNK1 in response to dietary K+ contribute to the physiologic regulation of renal K+ excretion (62–65).
Under normal circumstances, long WNK1 prevents the ability of WNK4 to inhibit activity of the Na+-Cl− cotransporter in the DCT. Thus, increased activity of long WNK1 leads to a net increase in NaCl reabsorption. Dietary K+ loading increases the abundance of KS-WNK1. Increased KS-WNK1 antagonizes the inhibitory effect of long WNK1 on WNK4. The net effect is inhibition of Na+-Cl− cotransport in the DCT and increased Na+ delivery to more distal parts of the tubule. In addition, increased KS-WNK1 antagonizes the effect of long WNK1 to stimulate endocytosis of ROMK. Furthermore, KS-WNK1 exerts a stimulatory effect on the ENaC. Thus, increases in KS-WNK1 in response to dietary K+ loading facilitate K+ secretion through the combined effects of increased Na+ delivery through downregulation of Na+-Cl− cotransport in the DCT, increased electrogenic Na+ reabsorption through the ENaC, and greater abundance of ROMK.
Increased aldosterone levels in response to a high K+ diet lead to effects that complement the effects of KS-WNK1 (66,67). The serum- and glucocorticoid-dependent protein kinase (SGK1) is an immediate transcriptional target of aldosterone binding to the mineralocorticoid receptor. Activation of SGK1 leads to phosphorylation of WNK4, resulting in a loss of the ability of WNK4 to inhibit ROMK and the ENaC (66,68). Aldosterone-induced activation of SGK1 also leads to increased ENaC expression and activity by causing the phosphorylation of ubiquitin protein ligase Nedd4–2. Phosphorylated Nedd4–2 results in less retrieval of ENaC from the apical membrane (69). It should be emphasized that the absence of AII is a critical factor in the ability of high K+ intake to bring about the changes necessary to facilitate K+ secretion without excessive Na+ reabsorption.
Role in Hypertension
Changes in KS-WNK1 and long WNK1 that occur in response to dietary K+ intake affect renal Na+ handling in a way that may be of importance in the observed relationship between dietary K+ intake and hypertension. Epidemiologic studies established that K+ intake is inversely related to the prevalence of hypertension (70). In addition, K+ supplements and avoidance of hypokalemia lowers BP in hypertensive subjects. By contrast, BP increases in hypertensive subjects placed on a low K+ diet. This increase in BP is associated with increased renal Na+ reabsorption (71).
K+ deficiency increases the ratio of long WNK1 to KS-WNK1. Long WNK1 is associated with increased retrieval of ROMK, thus providing an appropriate response to limit K+ secretion. However, long WNK1 also leads to a stimulatory effect on ENaC activity as well as releasing the inhibitory effect of WNK4 on Na+ reabsorption mediated by the NaCl cotransporter in the DCT (72,73). These effects suggest that reductions in K+ secretion under conditions of K+ deficiency will occur at the expense of increased Na+ retention.
Renal conservation of K+ and Na+ under conditions of K+ deficiency may be considered an evolutionary adaptation, because dietary K+ and Na+ deficiency likely occurred together for early humans (74). However, such an effect is potentially deleterious in our present setting, because evolution has seen a large increase in the ratio of dietary intake of Na+ versus K+. The effects of an increased ratio of WNK1 to KS-WNK1 in the kidney under conditions of modern day high Na+/low K+ diet could be central to the pathogenesis of salt-sensitive hypertension (75).
Enteric Sensor of K+
There is evidence to support the existence of enteric solute sensors capable of responding to dietary Na+, K+, and phosphate that signal the kidney to rapidly alter ion excretion or reabsorption (76–78). In experimental animals, and using protocols to maintain identical plasma K+ concentration, the kaliuretic response to a K+ load is greater when given as a meal compared with an intravenous infusion (79). These studies suggest that dietary K+ intake through a splanchnic sensing mechanism can signal increases in renal K+ excretion independent of changes in plasma K+ concentration or aldosterone (reviewed in ref. 80).
Although the precise signaling mechanism is not known, recent studies suggest that the renal response may be because of rapid and nearly complete dephosphorylation of the Na+-Cl− cotransporter in the DCT, causing decreased activity of the transporter and, thus, enhancing delivery of Na+ to the ASDN (81,82). In these studies, gastric delivery of K+ led to dephosphorylation of the cotransporter within minutes independent of aldosterone and based on in vitro studies, independent of changes in extracellular K+ concentration. The temporally associated increase in renal K+ excretion results from a more favorable electrochemical driving force caused by the downstream shift in Na+ reabsorption from the DCT to the ENaC in the ASDN as well as increased maxi-K+ channel K+ secretion brought on by increased flow. This rapid natriuretic response to increases in dietary K+ intake is consistent with the BP-lowering effect of K+-rich diets discussed earlier.
Circadian Rhythm of K+ Secretion
During a 24-hour period, urinary K+ excretion varies in response to changes in activity and fluctuations in K+ intake caused by the spacing of meals. However, even when K+ intake and activity are evenly spread over a 24-hour period, there remains a circadian rhythm whereby K+ excretion is lower at night and in the early morning hours and then increases in the afternoon (83–86). This circadian pattern results from changes in intratubular K+ concentration in the collecting duct as opposed to variations in urine flow rate (87).
In the mouse distal nephron, a circadian rhythm exists for gene transcripts that encode proteins involving K+ secretion (88). Gene expression of ROMK is greater during periods of activity, whereas expression of the H+-K+-ATPase is higher during rest, which correspond to periods when renal K+ excretion is greater and less, respectively (89). Changes in plasma aldosterone levels may play a contributory role, because circadian rhythm of glucocorticoid synthesis and secretion has been described in the adrenal gland. In addition, expression of clock genes within cells of the distal nephron suggests that a pacemaker function regulating K+ transport may be an intrinsic component of the kidney that is capable of operating independent of outside influence.
The clinical significance of this rhythmicity in K+ and other electrolyte secretions is not known. Evidence suggests that dysregulation of circadian rhythms may contribute to a lack of nocturnal decline in BP, with eventual development of sustained hypertension as well as accelerated CKD and cardiovascular disease (85,90).
Published online ahead of print. Publication date available at www.cjasn.org.
1. Palmer BF: A physiologic-based approach to the evaluation of a patient with hyperkalemia. Am J Kidney Dis 56: 387–393, 2010
2. Foley K, Boguslavsky S, Klip A: Endocytosis, recycling, and regulated exocytosis of glucose transporter 4. Biochemistry 50: 3048–3061, 2011
3. Ho K: A critically swift response: Insulin-stimulated potassium
and glucose transport in skeletal muscle. Clin J Am Soc Nephrol 6: 1513–1516, 2011
4. Nguyen TQ, Maalouf NM, Sakhaee K, Moe OW: Comparison of insulin action on glucose versus potassium
uptake in humans. Clin J Am Soc Nephrol 6: 1533–1539, 2011
5. Alvestrand A, Wahren J, Smith D, DeFronzo RA: Insulin-mediated potassium
uptake is normal in uremic and healthy subjects. Am J Physiol 246: E174–E180, 1984
6. Williams ME, Gervino EV, Rosa RM, Landsberg L, Young JB, Silva P, Epstein FH: Catecholamine modulation of rapid potassium
shifts during exercise. N Engl J Med 312: 823–827, 1985
7. Clausen T, Nielsen OB: Potassium
, Na+,K+-pumps and fatigue in rat muscle. J Physiol 584: 295–304, 2007
8. McKenna MJ, Bangsbo J, Renaud JM: Muscle K+, Na+, and Cl disturbances and Na+-K+ pump inactivation: Implications for fatigue. J Appl Physiol (1985) 104: 288–295, 2008
9. Clifford PS: Skeletal muscle vasodilatation at the onset of exercise. J Physiol 583: 825–833, 2007
10. Aronson PS, Giebisch G: Effects of pH on potassium
: New explanations for old observations. J Am Soc Nephrol 22: 1981–1989, 2011
11. Knochel JP, Dotin LN, Hamburger RJ: Pathophysiology of intense physical conditioning in a hot climate. I. Mechanisms of potassium
depletion. J Clin Invest 51: 242–255, 1972
12. McDonough AA, Youn JH: Role of muscle in regulating extracellular [K+]. Semin Nephrol 25: 335–342, 2005
13. Bundgaard H, Kjeldsen K: Potassium
depletion increases potassium
clearance capacity in skeletal muscles in vivo during acute repletion. Am J Physiol Cell Physiol 283: C1163–C1170, 2002
14. Bundgaard H: Potassium
depletion improves myocardial potassium
uptake in vivo. Am J Physiol Cell Physiol 287: C135–C141, 2004
15. Velázquez H, Ellison DH, Wright FS: Chloride-dependent potassium
secretion in early and late renal distal tubules. Am J Physiol 253: F555–F562, 1987
16. DuBose TD Jr., Codina J, Burges A, Pressley TA: Regulation of H(+)-K(+)-ATPase expression in kidney. Am J Physiol 269: F500–F507, 1995
17. Stokes JB: Mineralocorticoid effect on K+ permeability of the rabbit cortical collecting tubule. Kidney Int 28: 640–645, 1985
18. Palmer LG, Frindt G: High-conductance K channels in intercalated cells of the rat distal nephron. Am J Physiol Renal Physiol 292: F966–F973, 2007
19. Hebert SC, Desir G, Giebisch G, Wang W: Molecular diversity and regulation of renal potassium
channels. Physiol Rev 85: 319–371, 2005
20. Wang WH: Regulation of ROMK (Kir1.1) channels: New mechanisms and aspects. Am J Physiol Renal Physiol 290: F14–F19, 2006
21. Grimm PR, Sansom SC: BK channels in the kidney. Curr Opin Nephrol Hypertens 16: 430–436, 2007
22. Satlin LM, Carattino MD, Liu W, Kleyman TR: Regulation of cation transport in the distal nephron by mechanical forces. Am J Physiol Renal Physiol 291: F923–F931, 2006
23. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AE, Lu W, Brown EM, Quinn SJ, Ingber DE, Zhou J: Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 33: 129–137, 2003
24. Welling PA: Regulation of renal potassium
secretion: Molecular mechanisms. Semin Nephrol 33: 215–228, 2013
25. Pluznick JL, Sansom SC: BK channels in the kidney: Role in K(+) secretion and localization of molecular components. Am J Physiol Renal Physiol 291: F517–F529, 2006
26. Bailey MA, Cantone A, Yan Q, MacGregor GG, Leng Q, Amorim JB, Wang T, Hebert SC, Giebisch G, Malnic G: Maxi-K channels contribute to urinary potassium
excretion in the ROMK-deficient mouse model of Type II Bartter’s syndrome and in adaptation to a high-K diet. Kidney Int 70: 51–59, 2006
27. Gurkan S, Estilo GK, Wei Y, Satlin LM: Potassium
transport in the maturing kidney. Pediatr Nephrol 22: 915–925, 2007
28. Woda CB, Miyawaki N, Ramalakshmi S, Ramkumar M, Rojas R, Zavilowitz B, Kleyman TR, Satlin LM: Ontogeny of flow-stimulated potassium
secretion in rabbit cortical collecting duct
: Functional and molecular aspects. Am J Physiol Renal Physiol 285: F629–F639, 2003
29. Thayyil S, Kempley ST, Sinha A: Can early-onset nonoliguric hyperkalemia be predicted in extremely premature infants? Am J Perinatol 25: 129–133, 2008
30. Lindheimer MD, Richardson DA, Ehrlich EN, Katz AI: Potassium
homeostasis in pregnancy. J Reprod Med 32: 517–522, 1987
31. Elabida B, Edwards A, Salhi A, Azroyan A, Fodstad H, Meneton P, Doucet A, Bloch-Faure M, Crambert G: Chronic potassium
depletion increases adrenal progesterone production that is necessary for efficient renal retention of potassium
. Kidney Int 80: 256–262, 2011
32. Morimoto T, Liu W, Woda C, Carattino MD, Wei Y, Hughey RP, Apodaca G, Satlin LM, Kleyman TR: Mechanism underlying flow stimulation of sodium absorption in the mammalian collecting duct
. Am J Physiol Renal Physiol 291: F663–F669, 2006
33. Carattino MD, Sheng S, Kleyman TR: Mutations in the pore region modify epithelial sodium channel gating by shear stress. J Biol Chem 280: 4393–4401, 2005
34. van Ypersele de Strihou C: Potassium
homeostasis in renal failure. Kidney Int 11: 491–504, 1977
35. Stanton BA: Renal potassium
transport: Morphological and functional adaptations. Am J Physiol 257: R989–R997, 1989
36. Arroyo JP, Ronzaud C, Lagnaz D, Staub O, Gamba G: Aldosterone
paradox: Differential regulation of ion transport in distal nephron. Physiology (Bethesda) 26: 115–123, 2011
37. Palmer BF: A physiologic-based approach to the evaluation of a patient with hypokalemia. Am J Kidney Dis 56: 1184–1190, 2010
38. Field MJ, Stanton BA, Giebisch GH: Influence of ADH on renal potassium
handling: A micropuncture and microperfusion study. Kidney Int 25: 502–511, 1984
39. Cassola AC, Giebisch G, Wang W: Vasopressin increases density of apical low-conductance K+ channels in rat CCD. Am J Physiol 264: F502–F509, 1993
40. Kahle KT, Ring AM, Lifton RP: Molecular physiology of the WNK kinases. Annu Rev Physiol 70: 329–355, 2008
41. Kahle KT, Rinehart J, Giebisch G, Gamba G, Hebert SC, Lifton RP: A novel protein kinase signaling pathway essential for blood pressure regulation in humans. Trends Endocrinol Metab 19: 91–95, 2008
42. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z: Pseudohypoaldosteronism type II: Marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 87: 3248–3254, 2002
43. Gordon RD: The syndrome of hypertension and hyperkalaemia with normal GFR. A unique pathophysiological mechanism for hypertension? Clin Exp Pharmacol Physiol 13: 329–333, 1986
44. Yang SS, Morimoto T, Rai T, Chiga M, Sohara E, Ohno M, Uchida K, Lin SH, Moriguchi T, Shibuya H, Kondo Y, Sasaki S, Uchida S: Molecular pathogenesis of pseudohypoaldosteronism type II: Generation and analysis of a Wnk4(D561A/+) knockin mouse model. Cell Metab 5: 331–344, 2007
45. Lalioti MD, Zhang J, Volkman HM, Kahle KT, Hoffmann KE, Toka HR, Nelson-Williams C, Ellison DH, Flavell R, Booth CJ, Lu Y, Geller DS, Lifton RP: Wnk4 controls blood pressure and potassium
homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 38: 1124–1132, 2006
46. Yamauchi K, Rai T, Kobayashi K, Sohara E, Suzuki T, Itoh T, Suda S, Hayama A, Sasaki S, Uchida S: Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc Natl Acad Sci U S A 101: 4690–4694, 2004
47. Kahle KT, Wilson FH, Lifton RP: Regulation of diverse ion transport pathways by WNK4 kinase: A novel molecular switch. Trends Endocrinol Metab 16: 98–103, 2005
48. Castañeda-Bueno M, Gamba G: Mechanisms of sodium-chloride cotransporter modulation by angiotensin II. Curr Opin Nephrol Hypertens 21: 516–522, 2012
49. Castañeda-Bueno M, Cervantes-Pérez LG, Vázquez N, Uribe N, Kantesaria S, Morla L, Bobadilla NA, Doucet A, Alessi DR, Gamba G: Activation of the renal Na+:Cl- cotransporter by angiotensin II is a WNK4-dependent process. Proc Natl Acad Sci U S A 109: 7929–7934, 2012
50. Sun P, Yue P, Wang WH: Angiotensin II stimulates epithelial sodium channels in the cortical collecting duct
of the rat kidney. Am J Physiol Renal Physiol 302: F679–F687, 2012
51. van der Lubbe N, Zietse R, Hoorn EJ: Effects of angiotensin II on kinase-mediated sodium and potassium
transport in the distal nephron. Curr Opin Nephrol Hypertens 22: 120–126, 2013
52. Wei Y, Zavilowitz B, Satlin LM, Wang WH: Angiotensin II inhibits the ROMK-like small conductance K channel in renal cortical collecting duct
during dietary potassium
restriction. J Biol Chem 282: 6455–6462, 2007
53. Yue P, Sun P, Lin DH, Pan C, Xing W, Wang W: Angiotensin II diminishes the effect of SGK1 on the WNK4-mediated inhibition of ROMK1 channels. Kidney Int 79: 423–431, 2011
54. Halperin ML, Cheema-Dhadli S, Lin SH, Kamel KS: Control of potassium
excretion: A Paleolithic perspective. Curr Opin Nephrol Hypertens 15: 430–436, 2006
55. Cheema-Dhadli S, Lin SH, Keong-Chong C, Kamel KS, Halperin ML: Requirements for a high rate of potassium
excretion in rats consuming a low electrolyte diet. J Physiol 572: 493–501, 2006
56. Najjar F, Zhou H, Morimoto T, Bruns JB, Li HS, Liu W, Kleyman TR, Satlin LM: Dietary K+ regulates apical membrane expression of maxi-K channels in rabbit cortical collecting duct
. Am J Physiol Renal Physiol 289: F922–F932, 2005
57. Stokes JB: Consequences of potassium
recycling in the renal medulla. Effects of ion transport by the medullary thick ascending limb of Henle’s loop. J Clin Invest 70: 219–229, 1982
58. Sufit CR, Jamison RL: Effect of acute potassium
load on reabsorption in Henle’s loop in the rat. Am J Physiol 245: F569–F576, 1983
59. Brandis M, Keyes J, Windhager EE: Potassium
-induced inhibition of proximal tubular fluid reabsorption in rats. Am J Physiol 222: 421–427, 1972
60. Cheng CJ, Truong T, Baum M, Huang CL: Kidney-specific WNK1 inhibits sodium reabsorption in the cortical thick ascending limb. Am J Physiol Renal Physiol 303: F667–F673, 2012
61. Liu Z, Xie J, Wu T, Truong T, Auchus RJ, Huang CL: Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models. Hum Mol Genet 20: 855–866, 2011
62. O’Reilly M, Marshall E, Macgillivray T, Mittal M, Xue W, Kenyon CJ, Brown RW: Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo. J Am Soc Nephrol 17: 2402–2413, 2006
63. Wade JB, Fang L, Liu J, Li D, Yang CL, Subramanya AR, Maouyo D, Mason A, Ellison DH, Welling PA: WNK1 kinase isoform switch regulates renal potassium
excretion. Proc Natl Acad Sci U S A 103: 8558–8563, 2006
64. Lazrak A, Liu Z, Huang CL: Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Proc Natl Acad Sci U S A 103: 1615–1620, 2006
65. Cope G, Murthy M, Golbang AP, Hamad A, Liu CH, Cuthbert AW, O’Shaughnessy KM: WNK1 affects surface expression of the ROMK potassium
channel independent of WNK4. J Am Soc Nephrol 17: 1867–1874, 2006
66. Ring AM, Leng Q, Rinehart J, Wilson FH, Kahle KT, Hebert SC, Lifton RP: An SGK1 site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone
signaling and K+ homeostasis. Proc Natl Acad Sci U S A 104: 4025–4029, 2007
67. Náray-Fejes-Tóth A, Snyder PM, Fejes-Tóth G: The kidney-specific WNK1 isoform is induced by aldosterone
and stimulates epithelial sodium channel-mediated Na+ transport. Proc Natl Acad Sci U S A 101: 17434–17439, 2004
68. Lin DH, Yue P, Rinehart J, Sun P, Wang Z, Lifton R, Wang WH: Protein phosphatase 1 modulates the inhibitory effect of With-no-Lysine kinase 4 on ROMK channels. Am J Physiol Renal Physiol 303: F110–F119, 2012
69. Palmer BF, Alpern RJ: Liddle’s syndrome. Am J Med 104: 301–309, 1998
70. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM; American Heart Association: Dietary approaches to prevent and treat hypertension: A scientific statement from the American Heart Association. Hypertension 47: 296–308, 2006
71. Krishna GG, Kapoor SC: Potassium
depletion exacerbates essential hypertension. Ann Intern Med 115: 77–83, 1991
72. Vallon V, Wulff P, Huang DY, Loffing J, Völkl H, Kuhl D, Lang F: Role of Sgk1 in salt and potassium
homeostasis. Am J Physiol Regul Integr Comp Physiol 288: R4–R10, 2005
73. Rozansky DJ: The role of aldosterone
in renal sodium transport. Semin Nephrol 26: 173–181, 2006
74. Eaton SB: The ancestral human diet: What was it and should it be a paradigm for contemporary nutrition? Proc Nutr Soc 65: 1–6, 2006
75. Huang CL, Kuo E: Mechanisms of disease: WNK-ing at the mechanism of salt-sensitive hypertension. Nat Clin Pract Nephrol 3: 623–630, 2007
76. Thomas L, Kumar R: Control of renal solute excretion by enteric signals and mediators. J Am Soc Nephrol 19: 207–212, 2008
77. Michell AR, Debnam ES, Unwin RJ: Regulation of renal function by the gastrointestinal tract: Potential role of gut-derived peptides and hormones. Annu Rev Physiol 70: 379–403, 2008
78. Lee FN, Oh G, McDonough AA, Youn JH: Evidence for gut factor in K+ homeostasis. Am J Physiol Renal Physiol 293: F541–F547, 2007
79. Oh KS, Oh YT, Kim SW, Kita T, Kang I, Youn JH: Gut sensing of dietary K+ intake increases renal K+ excretion. Am J Physiol Regul Integr Comp Physiol 301: R421–R429, 2011
80. Youn JH: Gut sensing of potassium
intake and its role in potassium
homeostasis. Semin Nephrol 33: 248–256, 2013
81. Sorensen MV, Grossmann S, Roesinger M, Gresko N, Todkar AP, Barmettler G, Ziegler U, Odermatt A, Loffing-Cueni D, Loffing J: Rapid dephosphorylation of the renal sodium chloride cotransporter in response to oral potassium
intake in mice. Kidney Int 83: 811–824, 2013
82. McDonough AA, Youn JH: Need to quickly excrete K(+)? Turn off NCC. Kidney Int 83: 779–782, 2013
83. Firsov D, Tokonami N, Bonny O: Role of the renal circadian timing system in maintaining water and electrolytes homeostasis. Mol Cell Endocrinol 349: 51–55, 2012
84. Firsov D, Bonny O: Circadian regulation of renal function. Kidney Int 78: 640–645, 2010
85. Bonny O, Firsov D: Circadian regulation of renal function and potential role in hypertension. Curr Opin Nephrol Hypertens 22: 439–444, 2013
86. Gumz ML, Rabinowitz L: Role of circadian rhythms in potassium
homeostasis. Semin Nephrol 33: 229–236, 2013
87. Steele A, deVeber H, Quaggin SE, Scheich A, Ethier J, Halperin ML: What is responsible for the diurnal variation in potassium
excretion? Am J Physiol 267: R554–R560, 1994
88. Zuber AM, Centeno G, Pradervand S, Nikolaeva S, Maquelin L, Cardinaux L, Bonny O, Firsov D: Molecular clock is involved in predictive circadian adjustment of renal function. Proc Natl Acad Sci U S A 106: 16523–16528, 2009
89. Salhi A, Centeno G, Firsov D, Crambert G: Circadian expression of H,K-ATPase type 2 contributes to the stability of plasma K+ levels. FASEB J 26: 2859–2867, 2012
90. Gumz ML, Stow LR, Lynch IJ, Greenlee MM, Rudin A, Cain BD, Weaver DR, Wingo CS: The circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice. J Clin Invest 119: 2423–2434, 2009
91. Wakabayashi M, Mori T, Isobe K, Sohara E, Susa K, Araki Y, Chiga M, Kikuchi E, Nomura N, Mori Y, Matsuo H, Murata T, Nomura S, Asano T, Kawaguchi H, Nonoyama S, Rai T, Sasaki S, Uchida S: Impaired KLHL3-mediated ubiquitination of WNK4 causes human hypertension. Cell Rep 3: 858–868, 2013
92. Shibata S, Zhang J, Puthumana J, Stone KL, Lifton RP: Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4. Proc Natl Acad Sci U S A 110: 7838–7843, 2013
93. Hoorn EJ, Nelson JH, McCormick JA, Ellison DH: The WNK kinase network regulating sodium, potassium
, and blood pressure. J Am Soc Nephrol 22: 605–614, 2011